Investing.com - Select Medical (NYSE: SEM) reported second quarter EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $1.76B versus the consensus estimate of $1.74B.
Guidance
Select Medical sees FY 2024 EPS of $1.96-$2.20 versus the analyst consensus of $2.12.
Select Medical sees FY 2024 revenue of $6.90B-$7.10B versus the analyst consensus of $7.01B.
Select Medical's stock price closed at $39.18. It is up 24.66% in the last 3 months and up 29.05% in the last 12 months.
Select Medical saw 0 positive EPS revisions and 5 negative EPS revisions in the last 90 days. See Select Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Select Medical's Financial Health score is "great performance".
Check out Select Medical's recent earnings performance, and Select Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar